Pharsight

Drugs that contain Desmopressin Acetate

1. Nocdurna patents expiration

NOCDURNA's oppositions filed in EPO
NOCDURNA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9504647 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(10 months ago)

US9220747 FERRING PHARMS INC Methods using desmopressin acetate in orodispersible form
May, 2023

(10 months ago)

US9919025 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(10 months ago)

US10307459 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(10 months ago)

US7947654 FERRING PHARMS INC Pharmaceutical formulations
Dec, 2023

(2 months ago)

US8802624 FERRING PHARMS INC Methods of treatment using orodispersible desmopressin pharmaceutical formulations
Dec, 2023

(2 months ago)

US7560429 FERRING PHARMS INC Orodispersible dosage forms of desmopressin acetate
Feb, 2024

(a month ago)

US10137167 FERRING PHARMS INC Methods comprising desmopressin
May, 2029

(5 years from now)

US11020448 FERRING PHARMS INC Methods comprising desmopressin
May, 2029

(5 years from now)

US9974826 FERRING PHARMS INC Methods comprising desmopressin
Apr, 2030

(6 years from now)

Market Authorisation Date: 21 June, 2018

Treatment: Treatment of nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults, comprising monitoring a patient's serum sodium concentration

Dosage: TABLET;SUBLINGUAL

More Information on Dosage

NOCDURNA family patents

Family Patents

2. Noctiva patents expiration

NOCTIVA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7405203 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(10 months ago)

US7579321 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
May, 2023

(10 months ago)

US7799761 SERENITY PHARMS LLC Pharmaceutical compositions including low dosages of desmopressin
Sep, 2024

(5 months from now)

US11419914 SERENITY PHARMS LLC Safe desmopressin administration
Jun, 2030

(6 years from now)

US9539302 SERENITY PHARMS LLC Safe desmopressin administration
Jun, 2030

(6 years from now)

Market Authorisation Date: 03 March, 2017

Treatment: A method of treating nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void by inducing an antidiuretic e...

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

NOCTIVA family patents

Family Patents